Skip to content
Unrated Drug recall · FDA · Published January 13, 2023

Sun Pharmaceutical Diltiazem Capsules Recall: Failed Impurity Testing

Sun Pharmaceutical recalls 360mg Diltiazem Hydrochloride Extended-Release Capsules due to failed impurity and dissolution testing. Rx-only bottles with specific lot numbers and expiration dates are affected.

🇺🇸 FDA recall #D-0262-2023DrugSun Pharmaceutical ›
Take action

Contact the company

Recalling firmSUN PHARMACEUTICAL INDUSTRIES INC2 Independence Way · Princeton, NJ 08540-6620
✎ GovInfoNow plain-language explainer

Sun Pharmaceutical is recalling 360mg Diltiazem Hydrochloride Extended-Release Capsules that failed stability and dissolution tests. This means the capsules may contain unsafe impurities that could cause health risks if taken. Read more at govinfonow.com/recall/34002-sun-pharmaceutical-diltiazem-capsules-recall-failed-impurity-testing.

Source Summary by GovInfoNow · govinfonow.com/recall/34002-sun-pharmaceutical-diltiazem-capsules-recall-failed-impurity-testing · Updated August 18, 2026 · FDA enforcement record: FDA #D-0262-2023

Cite this page

“Sun Pharmaceutical Diltiazem Capsules Recall: Failed Impurity Testing.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/34002-sun-pharmaceutical-diltiazem-capsules-recall-failed-impurity-testing. Based on FDA recall #D-0262-2023 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0262-2023%22&limit=1).

Sun Pharmaceutical Industries Inc. recalled Diltiazem Hydrochloride Extended-Release Capsules, USP, 360 mg on Jan. 13, 2023, after failed impurity and dissolution testing, according to the FDA.

How to tell if you have it

  • Brand: Sun Pharmaceutical
  • Product: Diltiazem Hydrochloride Extended-Release Capsules, USP, 360 mg
  • Packaging: 90-count bottles
  • NDC: 47335-679-81
  • Lot codes: HAC3120A (Exp. 04/2023), HAC3121A (Exp. 10/2023), HAC4460A (Exp. 12/2023), HAD0365A (Exp. 02/2024), HAD1452A (Exp. 02/2024)
  • Distribution: Nationwide in the U.S.

The hazard

The recall was issued due to failed impurity specifications for Deacetyl Diltiazem Hydrochloride during stability testing and failed dissolution testing at an FDA laboratory.

Context

GovInfoNow's records show Sun Pharmaceutical Industries Inc. has 93 other recalls on record since May 21, 2013. Other recent recalls of similar products include Sun Pharmaceutical Nystatin Cream Recall (Sept. 14, 2026), Sun Pharmaceutical Carbamazepine Tablets Recall (Aug. 3, 2026), and Sun Pharmaceutical Perampanel 6mg Tablets Recall (June 17, 2026).

How to tell if you have this one

Check the bottle for the lot numbers: HAC3120A, HAC3121A (expiring 04/2023), HAC4460A (expiring 10/2023), HAD0365A (expiring 12/2023), or HAD1452A (expiring 02/2024). The product is a prescription-only 360mg capsule.

  • Brand
    Sun Pharmaceutical
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Look for the lot numbers HAC3120A, HAC3121A, HAC4460A, HAD0365A, or HAD1452A on the bottle.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide in the U.S.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 9 months after the firm started it.

1. Firm started the recall: Jan 13, 202312. FDA classified it Class II: Feb 2, 202323. Published in FDA’s Enforcement Report: Feb 8, 202334. FDA terminated the recall: Oct 27, 202342023
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Sun Pharmaceutical recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0262-2023 (January 13, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0262-2023 to see it in context.
  • Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA